Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Axis NIFTY Healthcare ETF Reg (G) |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.09 |
Equity |
99.82 |
Trep |
0.09 |
|
|
Concentration Analysis |
Top 5 Holdings |
54.38% |
Top 10 Holdings |
78.07% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
76.89 |
Healthcare |
22.93 |
Cash |
0.18 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.48 |
PE Ratio |
38.06 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
18.72 |
Max Healthcare Institute Limited |
9.82 |
DIVI LABORATORIES LTD. |
8.96 |
Cipla Limited |
8.78 |
Dr Reddys Laboratories Limited |
8.10 |
Apollo Hospitals Enterprise Limited |
7.58 |
Lupin Limited |
4.85 |
Fortis Health Care Ltd |
4.28 |
Torrent Pharmaceuticals Limited |
3.69 |
Aurobindo Pharma Limited |
3.29 |
Laurus Labs Limited |
2.94 |
Alkem Laboratories Limited |
2.75 |
Glenmark Pharmaceuticals Limited |
2.74 |
Mankind Pharma Limited |
2.71 |
Zydus Lifesciences Limited |
2.56 |
Biocon Limited |
2.14 |
IPCA Laboratories Limited |
2.00 |
Abbott India Limited |
1.92 |
Syngene International Limited |
1.25 |
Granules India Limited |
0.74 |
Clearing Corporation of India Limited |
0.09 |
Net Receivables / (Payables) |
0.07 |
Net Current Assets |
0.02 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|